• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人起病型微小病变肾病综合征的类固醇反应性及复发频率

Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.

作者信息

Nakayama Masaru, Katafuchi Ritsuko, Yanase Tetsuro, Ikeda Kiyoshi, Tanaka Hiroshi, Fujimi Satoru

机构信息

First Department of Internal Medicine, Fukuoka Red Cross Hospital, Fukuoka, Japan.

出版信息

Am J Kidney Dis. 2002 Mar;39(3):503-12. doi: 10.1053/ajkd.2002.31400.

DOI:10.1053/ajkd.2002.31400
PMID:11877569
Abstract

To clarify factors influencing the response to corticosteroids and subsequent relapses, 62 Japanese adult patients with minimal change nephrotic syndrome were analyzed retrospectively. Five patients experienced remission spontaneously. Fifty-three patients entered complete remission, 3 patients entered partial remission, and 1 patient showed no response to corticosteroids. Fifty-three patients with complete remission were divided into two groups: 38 early responders who experienced remission completely within 8 weeks after starting treatment and 15 late responders who experienced remission after 8 weeks. Blood urea nitrogen and serum creatinine levels and proteinuria selectivity index at presentation were significantly worse in late than early responders. Relative interstitial volume determined by the point-counting method was significantly greater in late than early responders. Relative interstitial volume showed significant correlations with blood urea nitrogen, serum creatinine, and proteinuria selectivity index values. Thirty-three patients experienced a relapse; 13 patients experienced multiple relapses. Fifty-three patients with remission were divided into three groups: 16 patients who experienced relapse within 6 months after the initial response (early relapsers), 17 patients who experienced relapse after 6 months (late relapsers), and 20 patients who did not experience relapse (nonrelapsers). Mean age at onset was younger in early relapsers than late or nonrelapsers. Age at onset correlated inversely with relapse rate in 53 patients with remission and correlated positively with timing of the first relapse in 33 relapsers. It thus was suggested that impaired renal function and poor selectivity of proteinuria, which might be related to interstitial edema, were factors influencing a slower response to corticosteroids. Younger patients had a greater incidence of relapse and were prone to experience relapse earlier.

摘要

为了阐明影响对皮质类固醇反应及随后复发的因素,我们对62例日本成年微小病变型肾病综合征患者进行了回顾性分析。5例患者自发缓解。53例患者完全缓解,3例患者部分缓解,1例患者对皮质类固醇无反应。53例完全缓解的患者分为两组:38例早期缓解者在开始治疗后8周内完全缓解,15例晚期缓解者在8周后缓解。就诊时晚期缓解者的血尿素氮、血清肌酐水平及蛋白尿选择性指数明显比早期缓解者差。采用点计数法测定的相对间质容积晚期缓解者明显大于早期缓解者。相对间质容积与血尿素氮、血清肌酐及蛋白尿选择性指数值显著相关。33例患者复发;13例患者多次复发。53例缓解患者分为三组:16例在初次缓解后6个月内复发的患者(早期复发者),17例在6个月后复发的患者(晚期复发者),20例未复发的患者(未复发者)。早期复发者的发病平均年龄比晚期复发者或未复发者年轻。发病年龄与53例缓解患者的复发率呈负相关,与33例复发患者首次复发的时间呈正相关。因此提示,肾功能受损及蛋白尿选择性差,可能与间质水肿有关,是影响对皮质类固醇反应较慢的因素。年轻患者复发率较高且易于较早复发。

相似文献

1
Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.成人起病型微小病变肾病综合征的类固醇反应性及复发频率
Am J Kidney Dis. 2002 Mar;39(3):503-12. doi: 10.1053/ajkd.2002.31400.
2
Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.环孢素 A 联合泼尼松治疗成人微小病变肾病综合征首次复发。
Nephrol Dial Transplant. 2010 Jan;25(1):124-9. doi: 10.1093/ndt/gfp422. Epub 2009 Sep 9.
3
Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.环孢素对特发性肾病综合征患儿的长期影响:单中心经验
Nephrol Dial Transplant. 2005 Nov;20(11):2433-8. doi: 10.1093/ndt/gfi059. Epub 2005 Oct 4.
4
The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.环孢素A治疗成人微小病变型肾病和局灶节段性肾小球硬化所致肾病综合征的疗效:韩国一项多中心研究
Clin Nephrol. 1995 Jun;43(6):375-81.
5
Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study.环孢素长期治疗微小病变型肾病综合征:一项对照活检研究。
Nephrol Dial Transplant. 1988;3(6):733-7.
6
Adult minimal-change disease: clinical characteristics, treatment, and outcomes.成人微小病变病:临床特征、治疗及预后
Clin J Am Soc Nephrol. 2007 May;2(3):445-53. doi: 10.2215/CJN.03531006. Epub 2007 Apr 11.
7
Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.他克莫司与环孢素治疗儿童激素抵抗型肾病综合征的疗效及安全性:一项随机对照试验
Am J Kidney Dis. 2009 May;53(5):760-9. doi: 10.1053/j.ajkd.2008.11.033. Epub 2009 Mar 5.
8
Glomerular glucocorticoid receptor expression is reduced in late responders to steroids in adult-onset minimal change disease.在成人起病的微小病变病中,对类固醇反应迟缓者的肾小球糖皮质激素受体表达降低。
Nephrol Dial Transplant. 2008 Jan;23(1):169-75. doi: 10.1093/ndt/gfm575. Epub 2007 Sep 22.
9
Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.长期服用硫唑嘌呤对患有微小病变性肾小球肾炎且对皮质类固醇耐药的成人肾病综合征的影响。
Arch Intern Med. 1986 Apr;146(4):737-41.
10
Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.环孢素治疗儿童特发性微小病变肾病综合征的单中心经验
Iran J Kidney Dis. 2009 Jul;3(3):127-35.

引用本文的文献

1
The clinical course of SARS-CoV-2 infection in patients with glomerular diseases and evaluation of the subsequent risk of relapse.肾小球疾病患者感染新型冠状病毒2的临床病程及后续复发风险评估
Front Nephrol. 2024 Oct 21;4:1472294. doi: 10.3389/fneph.2024.1472294. eCollection 2024.
2
Relationship between time to clinical remission and relapse in adults with steroid-sensitive minimal change disease: a retrospective cohort study.成人激素敏感型微小病变性肾病临床缓解至复发时间的关系:一项回顾性队列研究。
Ann Med. 2024 Dec;56(1):2409344. doi: 10.1080/07853890.2024.2409344. Epub 2024 Oct 10.
3
Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis.
成人类固醇依赖型或频繁复发型肾病综合征的免疫抑制治疗:系统评价和荟萃分析。
PLoS One. 2024 Jul 31;19(7):e0307981. doi: 10.1371/journal.pone.0307981. eCollection 2024.
4
Relapse during and after regular single-dose rituximab treatment in adult patients with steroid-dependent nephrotic syndrome.在接受常规单剂量利妥昔单抗治疗的成人类固醇依赖性肾病综合征患者中,治疗期间和治疗后出现复发。
Clin Exp Nephrol. 2024 Nov;28(11):1082-1089. doi: 10.1007/s10157-024-02508-4. Epub 2024 Jun 4.
5
[Diagnosis and treatment of Minimal Change Disease in adults-2023].[成人微小病变病的诊断与治疗 - 2023]
Wien Klin Wochenschr. 2023 Aug;135(Suppl 5):628-637. doi: 10.1007/s00508-023-02258-5. Epub 2023 Sep 20.
6
Outcomes of minimal change disease without nephrotic range proteinuria.无微小球性肾炎肾病范围蛋白尿的结局。
PLoS One. 2023 Aug 17;18(8):e0289870. doi: 10.1371/journal.pone.0289870. eCollection 2023.
7
Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS.重复给予利妥昔单抗可使 MCD 或 FSGS 患者达到并维持临床缓解。
Sci Rep. 2023 Apr 28;13(1):6980. doi: 10.1038/s41598-023-32576-7.
8
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse.低剂量利妥昔单抗治疗微小病变性肾病及预防复发的疗效。
BMC Nephrol. 2023 Apr 26;24(1):112. doi: 10.1186/s12882-023-03092-7.
9
A case of minimal change nephrotic syndrome complicated by Kimura disease treated with rituximab.一例微小病变性肾病综合征并发 Kimura 病患者接受利妥昔单抗治疗。
CEN Case Rep. 2023 Nov;12(4):368-373. doi: 10.1007/s13730-023-00778-7. Epub 2023 Feb 21.
10
Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.局灶节段性肾小球硬化症和微小病变性肾病的潜在尿液蛋白质组生物标志物。
Int J Mol Sci. 2022 Oct 20;23(20):12607. doi: 10.3390/ijms232012607.